biologic

  1. T

    REMICADE® Receives FDA Approval As First Biologic Treatment For Pediatric Ulcerative

    Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy. This marks the...
  2. T

    Ethicon Submits Biologic License Application To The FDA For The Fibrin Pad

    Ethicon, Inc., a worldwide leader in surgical care, announced that the company has submitted a Biologic License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the Fibrin Pad, a novel product candidate that combines Ethicon's biomaterials and plasma-derived biologics (Human...
Top